260 related articles for article (PubMed ID: 25152614)
1. Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.
Peng PJ; Cheng H; Ou XQ; Zeng LJ; Wu X; Liu YM; Lin Z; Tang YN; Wang SY; Zhang HY; Chen ZB
Drug Des Devel Ther; 2014; 8():1083-7. PubMed ID: 25152614
[TBL] [Abstract][Full Text] [Related]
2. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
3. Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma.
Zhou L; Lin J; Wu G; Chen J; Huang X; Zhang S
Drug Des Devel Ther; 2020; 14():1257-1262. PubMed ID: 32280197
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
Suzuki S; Ishikawa K
J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.
Peng PJ; Lv BJ; Wang ZH; Liao H; Liu YM; Lin Z; Con YY; Huang PY
Ther Adv Med Oncol; 2017 Feb; 9(2):68-74. PubMed ID: 28203299
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of the oral chemotherapy agent S-1 in heavily pre-treated patients with advanced or recurrent cervical cancer.
Tanigawa T; Matoda M; Yamamoto A; Nomura H; Okamoto S; Sakamoto K; Kondo E; Omatsu K; Kato K; Takeshima N
Arch Gynecol Obstet; 2016 Mar; 293(3):633-8. PubMed ID: 26305033
[TBL] [Abstract][Full Text] [Related]
7. An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
Naito S; Tsukamoto T; Usami M; Fujimoto H; Akaza H
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1065-70. PubMed ID: 20157711
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
9. Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy.
Zhang Y; Zhao L; Huang P; Wu J; Wang F; Huang Y; Zhang L
Cancer Chemother Pharmacol; 2012 Oct; 70(4):611-5. PubMed ID: 22903536
[TBL] [Abstract][Full Text] [Related]
10. Outpatient chemotherapy with S-1 for recurrent head and neck cancer.
Yamashita T; Shinden S; Watabe T; Shiotani A
Anticancer Res; 2009 Feb; 29(2):577-81. PubMed ID: 19331206
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial.
Huang J; Xu B; Liu Y; Huang J; Lu P; Ba Y; Wu L; Bai Y; Zhang S; Feng J; Cheng Y; Li J; Wen L; Yuan X; Ma C; Hu C; Fan Q; Wang X
Cancer Commun (Lond); 2019 Apr; 39(1):16. PubMed ID: 30940189
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
Chua D; Wei WI; Sham JS; Au GK
Jpn J Clin Oncol; 2008 Apr; 38(4):244-9. PubMed ID: 18407933
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.
Peng P; Ou X; Liao H; Liu Y; Wang S; Cheng Z; Lin Z
Ther Adv Med Oncol; 2016 May; 8(3):153-9. PubMed ID: 27239233
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
Narahara H; Iishi H; Imamura H; Tsuburaya A; Chin K; Imamoto H; Esaki T; Furukawa H; Hamada C; Sakata Y
Gastric Cancer; 2011 Mar; 14(1):72-80. PubMed ID: 21340666
[TBL] [Abstract][Full Text] [Related]
16. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Takashima T; Mukai H; Hara F; Matsubara N; Saito T; Takano T; Park Y; Toyama T; Hozumi Y; Tsurutani J; Imoto S; Watanabe T; Sagara Y; Nishimura R; Shimozuma K; Ohashi Y;
Lancet Oncol; 2016 Jan; 17(1):90-8. PubMed ID: 26617202
[TBL] [Abstract][Full Text] [Related]
17. Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
Peng PJ; Ou XQ; Chen ZB; Liao H; Peng YL; Wang SY; Zhang HY; Lin Z
Cancer Chemother Pharmacol; 2013 Aug; 72(2):323-8. PubMed ID: 23728706
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.
Katsumata N; Hirai Y; Kamiura S; Sugiyama T; Kokawa K; Hatae M; Nishimura R; Ochiai K
Ann Oncol; 2011 Jun; 22(6):1353-1357. PubMed ID: 21345941
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer.
Ueda Y; Yamagishi H; Ichikawa D; Okamoto K; Otsuji E; Morii J; Koizumi K; Kakihara N; Shimotsuma M; Yamashita T; Taniguchi F; Aragane H; Nishi H; Itokawa Y; Morita S; Sakamoto J
Gastric Cancer; 2010 Aug; 13(3):149-54. PubMed ID: 20820983
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.
Tsushima T; Hironaka S; Boku N; Machida N; Yamazaki K; Yasui H; Taku K; Fukutomi A; Onozawa Y
Gastric Cancer; 2010 Nov; 13(4):245-50. PubMed ID: 21128060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
